Needham Maintains Buy on Shattuck Labs, Raises Price Target to $19

10/2/2026
Impact: 70
Healthcare

Needham analyst Joseph Stringer has maintained a 'Buy' rating on Shattuck Labs (NASDAQ: STTK) and raised the price target from $17 to $19.

AI summary, not financial advice

Share: